Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted.
Abbott Laboratories (NYSE:ABT) Shares Acquired by Harvest Portfolios Group Inc.
Abbott Laboratories stock opened at $106.22 on Tuesday.
America First Investment Advisors LLC’s holdings in Abbott Laboratories were worth $16,756,000 at the end of the most recent quarter.
An illustrative cross-section of Alteryx's customer base: Netflix (), Abbott Laboratories (), Marriott Hotels () are all among Alteryx's anchor clients, spanning every industry.
Barclays increased their price target on shares of Abbott Laboratories from $127.00 to $132.00 and gave the company an “overweight” rating in a research note on Monday, July 24th.
BTIG Research boosted their price objective on shares of Abbott Laboratories from $125.00 to $130.00 and gave the company a “buy” rating in a research report on Monday, April 17th.
Core Alternative Capital lifted its stake in Abbott Laboratories by 27.0% during the 2nd quarter.
EdgeRock Capital LLC acquired a new stake in shares of Abbott Laboratories during the third quarter worth about $29,000.
Finally, assumed coverage on shares of Abbott Laboratories in a research note on Thursday, October 5th.
Finally, Ridgewood Investments LLC acquired a new stake in Abbott Laboratories in the 1st quarter valued at about $36,000.
Finally, TheStreet lowered shares of Abbott Laboratories from a “b-” rating to a “c+” rating in a research report on Monday, October 16th.
In other Abbott Laboratories news, EVP sold 10,400 shares of the business’s stock in a transaction on Tuesday, August 8th.
In other Abbott Laboratories news, EVP sold 11,000 shares of the business’s stock in a transaction on Tuesday, December 13th.
In other Abbott Laboratories news, SVP Randel William Woodgrift sold 1,032 shares of the business’s stock in a transaction that occurred on Wednesday, March 1st.
Rehmann Capital Advisory Group’s holdings in Abbott Laboratories were worth $1,248,000 as of its most recent filing with the SEC.
Sell-side analysts anticipate that Abbott Laboratories will post 4.38 earnings per share for the current year.
State Street Corp boosted its holdings in Abbott Laboratories by 0.5% during the 3rd quarter.
The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada.
The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories ’ baby-formula business, the company said.